Manas Kumar Santra is an Indian cell biologist, biological chemist and a scientist at the National Centre for Cell Science (NCCS).[1] He is known for his studies on F-box proteins which is the research focus of his laboratory at NCCS[2] where he hosts a number of researchers.[3]
Chanukuppa V, Taware R, Chatterjee T, Sharma S, More TH, Taunk K, Kumar S, Santra MK, Rapole S (November 2018). "Current understanding of the potential of proteomics and metabolomics approaches in cancer chemoresistance: A focus on Multiple Myeloma". Current Topics in Medicinal Chemistry. 19 (30): 2584–2598. doi:10.2174/1568026619666181130111202. PMID30499398. S2CID54165255.
Ghosh C, Gupta N, More P, Sengupta P, Mallick A, Santra MK, Basu S (October 2016). "Engineering and In Vitro Evaluation of Acid Labile Cholesterol Tethered MG132 Nanoparticle for Targeting Ubiquitin-Proteasome System in Cancer". ChemistrySelect. 1 (16): 5099–5106. doi:10.1002/slct.201601117.
Mistri S, Paul A, Bhunia A, Manne RK, Santra MK, Puschmann H, Manna SC (28 January 2016). "A combined experimental and theoretical investigation on the Cu(II) sensing behavior of a piperazinyl moiety based ligand, and catecholase and biological activities of its Cu(II) complex in combination with pyridine 2,5-dicarboxylate". Polyhedron. 104: 63–72. doi:10.1016/j.poly.2015.11.030.
Bhunia A, Manna S, Mistri S, Paul A, Manne RK, Santra MK, Bertolasi V, Manna SC (6 August 2015). "Synthesis, characterization, TDDFT calculation and biological activity of tetradentate ligand based square pyramidal Cu(II) complexes". RSC Advances. 5 (83): 67727–67737. Bibcode:2015RSCAd...567727B. doi:10.1039/C5RA12324K.
